This study is not yet accepting patients
First in Human Study of TORL-4-500 in Participants With Advanced Cancer
Summary
- Eligibility
- for people ages 18 years and up (full criteria)
- Location
- at UCLA
- Dates
- study startestimated completion
Description
Summary
Official Title
Keywords
Eligibility
Location
Details
- Status
- not yet accepting patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- TORL Biotherapeutics, LLC
- ID
- NCT06005740
- Phase
- Phase 1 research study
- Study Type
- Interventional
- Participants
- Expecting 70 study participants
- Last Updated